A clean bill of health for LABAs?
Clinical and Experimental Sciences and Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.|NIHR Southampton Respiratory Biomedical Research Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK.|The David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Isle of Wight, UK.
G
G
Roberts
D058666:Adrenergic beta-2 Receptor Agonists / Q000009:adverse effects*; D000707:Anaphylaxis / Q000453:epidemiology*; D000818:Animals; D001249:Asthma / Q000188:drug therapy / Q000401:mortality; D003718:Denmark / Q000453:epidemiology; D004641:Emigration and Immigration; D005658:Fungi / Q000276:immunology; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D007074:Immunoglobulin G / Q000096:biosynthesis; D051379:Mice; D029424:Pulmonary Disease, Chronic Obstructive; D039981:Pyroglyphidae / Q000276:immunology*
D058666:Adrenergic beta-2 Receptor Agonists; D007074:Immunoglobulin G; D007073:Immunoglobulin E